NEW ORLEANS, October 20, 2026 ⎯ Answer ALS announced that the National Football League (NFL) has committed $500,000 to Champion Insights, a nationwide research study investigating why elite athletes, military veterans, and first responders develop ALS at higher rates than the general public. The study aims to uncover genetic and biological factors that may help…
Ambitious nationwide study will enroll 500 participants to examine genetic, biological, and environmental factors linked to elevated ALS risk. NEW ORLEANS, February 4, 2026 — Champion Insights officially commenced active research operations today in its nationwide study investigating why elite athletes, military veterans, and high-performance populations, like first responders, face disproportionately high rates — potentially up…
All data from 1,100+ Answer ALS participants, including ALS TDI’s ARC study data, are now harmonized and accessible via the Neuromine Data Portal, forming the world’s largest open ALS research resource to accelerate discoveries. NEW ORLEANS, November 03, 2025 — Answer ALS today announced the full release of its comprehensive ALS clinical and multi-omics dataset,…
State-of-the-art remote-participation research seeks to understand how genetic factors linked to intense activities and lipid metabolism may increase ALS susceptibility NEW ORLEANS, August 13, 2025 — Answer ALS, in collaboration with ALS Therapy Development Institute (ALS TDI) and Augie’s Quest, today announced plans to launch Champion Insights, an ambitious research initiative designed to uncover critical…
NEW ORLEANS, July 22, 2025 — Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed at accelerating AI-powered drug discovery for ALS and other neurodegenerative diseases. This effort, known as the Louisiana AI Drug Development Infrastructure for ALS (LADDIA), brings together leading institutions and innovators, including GATC Health — a…
Integrated data sharing platforms to accelerate research into ALS and Alzheimer’s disease by providing access to collaborative tools and datasets
Unprecedented resource, created with Cedars-Sinai, to accelerate ALS research and drive development of targeted therapies globally
The ALS Therapy Development Institute (ALS TDI), Answer ALS, and Microsoft are pleased to announce a collaboration that will bring together the two largest existing clinical and omics data sets relating to ALS. Through this partnership, comprehensive data collected through ALS TDI’s ALS Research Collaborative (ARC) will be added to Neuromine, an innovative data portal…
Dr. Jeffrey Keller to Co-Lead Answer ALS’ Unprecedented Open Access ALS Data Repository. Appointment to Answer ALS bridges revolutionary data repository with renowned biomedical research center. NEW ORLEANS, Louisiana—Answer ALS is excited to announce that Dr. Jeffrey Keller, Ph.D. has been selected as Answer ALS’ Principal Investigator over the program’s renowned open-access data repository, Neuromine….
FORT WORTH, Texas — American Airlines raised more than $1.2 million for Answer ALS this week through its annual Charity Golf Tournament presented by Citi. “We are honored to continue our partnership with Answer ALS and support them on their way to raising $45 million for this critical, first of its kind, research project,” said…
Microsoft is investing $1 million in cloud-computing resources for the nonprofit, which will make the huge repository of valuable data openly available to researchers around the globe. Maybe, Joel Shamaskin thought, he was working too many hours, not getting enough sleep. That wouldn’t have been unusual for the longtime primary care doctor at the University…
FORT WORTH, Texas – American Airlines raised more than $950,000 for Answer ALS through its third annual American Airlines Charity Golf Tournament. “We are proud to continue to partner with Answer ALS on behalf of the American Airlines family,” said chairman and CEO Doug Parker. “Many of our team members have been affected by ALS,…
Data & TechnologyHarnessing Big Data with Advanced Analytics Neuromine is one of the world’s most robust and comprehensive ALS data resources, integrating multi-omics, clinical, and cellular datasets, while also linking to coordinating iPSC lines, biosamples, and other large-scale data platforms with analytic tools to maximize discovery and collaboration.
Multi-Omnics AnalysisComprehensive Biological Data Integration Making a comprehensive multi-omics datasets available that integrates genomics, transcriptomics, proteomics, epigenomics, and iPSC-derived motor neuron data that is freely accessible for analysis.
IPS Cells & Motor NeuronsGenerated 1,000 Participant-Derived Cell Lines Learn More about how to access 1,000 iPSC lines through our partners at the Cedars-Sinai Biomanufacturing Center
Clinic & enrollmentLeading Clinics Engaged to Complete Enrollment Enrollment in the Answer ALS program is complete, but you can Learn More about connected programs like Champion Insights, ALS Therapy Development’s ARC Program
